GAMMA Investing’s CytomX Therapeutics CTMX Stock Holding History

GAMMA Investing’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.19K	Buy	+806	New	+$2.69K	﹤0.01%	3927

Other funds holding CTMX

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's CTMX Position: Q3 2026 in Review

GAMMA Investing opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 806 shares worth $2.19K. The stake represents ﹤0.01% of the portfolio and ranks #3927 among its holdings.

3 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

GAMMA Investing held 806 shares of CytomX Therapeutics worth $2.19K as of Q3 2026.
CytomX Therapeutics was a new GAMMA Investing position in Q3 2026.
CytomX Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3927 holding.
3 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.